
File this under “What were they thinking?”
In an embarrassing outcome for all concerned, Sunovion Pharmaceuticals was harshly reprimanded by a U.K. industry trade group for providing deceptive information to a panel that was investigating a Sunovion manager for using unethical tactics to boost prescriptions.